Canada is the only nation with a broad public health system lacking universal coverage for pharmaceuticals. Despite fears that pharmacare would be too costly, it could end up saving Canadians money.
Rigor académico, oficio periodístico
Artículos sobre Pharmacare
Mostrando 21 - 21 de 21 artículo
Principales colaboradores
-
Joel Lexchin es Amigo de The Conversation.Professor Emeritus of Health Policy and Management, York University, Canada
-
Associate Professor, Political Science, McMaster University
-
Assistant Professor, Department of Family and Community Medicine, University of Toronto
-
Graduate Student, University of Manitoba
-
Senior Instructor, University of Manitoba
-
Adjunct Professor, Faculty of Environmental and Urban Change, York University, Canada
-
Professor, School of Rehabilitation Therapy, Queen's University, Ontario
-
Assistant Professor of Pharmacy, University of Waterloo
-
Research Coordinator, Centre for Health Services and Policy Research and School of Rehabilitation Therapy, Queen's University, Ontario
-
Canada Research Chair in Health Justice, University of Toronto
-
Professor, School of Population and Public Health, University of British Columbia
-
Professor, Political Science, McGill University
-
PhD Student, Political Science, L’Université d’Ottawa/University of Ottawa
-
Associate Professor, University of Regina
-
PhD Candidate (Epidemiology), University of Toronto
